NCT02685345View on ClinicalTrials.gov

A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

DS-8500a 25 mg

DRUG

DS-8500a 75 mg

DRUG

placebo

Trial Locations (1)

565-0853

Yodogawaku

Sponsors
All Listed Sponsors
collaborator

Mediscience Planning, Inc.

INDUSTRY

lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT02685345 - A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin | Biotech Hunter | Biotech Hunter